HealthScienceTechnologyWorld

Global Insulin Drugs Market || keyplayers Wockhardt Limited Pfizer, Inc. YPSOMED Holding AG

Introduction:

Insulin is the protein hormone which is used to treat high blood glucose. It is also used as a medication to treat diabetes, gestational diabetes, Mellitus type 1, diabetes mellitus type 2 and complications of diabetes such as hyperosmolar hyperglycemic states and diabetic ketoacidosis. Generally, some forms of the insulin are given by injection under the skin, and some forms of insulin can also be given by injecting into muscles or veins.

Drivers and Restraints:

The government policies are favourable for the production of insulin which is the major propelling factor for the growth of the global insulin market. Additionally, the biotechnology and biopharmaceutical companies are focusing on the developing the advance medical device to deliver the insulin with less pain and safety in the body which is the boosting factor for the growth of the target market. Moreover, insulin is used to control the glycemic condition by which the risk of cardiovascular can be controlled which is another propelling factor for the growth of the global market. For instance, according to data collected by the WHO (World’s Health Organization) between the years 2016-2019 from the 24 countries, showed that the availability of human insulin is 61% of the health facilities and availability of analogue insulin is 13%. However, the cost of insulin is not affordable by everyone which is the restraining factor for the growth of the global market. Moreover, the lack of awareness about the insulin drug is another hampering factor for the growth of the target market. Nevertheless, the investment in research and development to reduce the prices of insulin can create an opportunity for the global insulin drugs market.

Request free sample:-https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3801

Global Insulin Drugs  Market, By Product Type, 2020 – 2030, (US$ Mn)

  • Overview
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
    • Y-o-Y Growth Analysis (%), 2020 – 2030
    • Segment Trends
  • Human Insulin
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  • Basal Insulin
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  • Bolus Insulin
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  • Insulin Combinations
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  • Biosimilar Insulin
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  • Company Profile:
    • Novo Nordisk AS *
          • Company Overview
          • Product Portfolio
          • Key Highlights
          • Financial Performance
    • Sanofi Aventis
    • Eli Lilly and Company
    • Biocon Limited
    • Julphar
    • Albireo Pharma, Inc.
    • Sedico
    • Wockhardt Limited
    • Pfizer, Inc.
    • YPSOMED Holding AG

Contact Us:

Mr. Alex (Sales Manager)

Prophecy Market Insights

Phone: +1 860 531 2701

+91 777 504 9802
Email: sales@prophecymarketinsights.com

Back to top button